PA
FSBC icon

PharVision Advisers’s Five Star Bancorp FSBC Stock Holding History

PharVision Advisers’s Portfolio FSBC Stock Details FSBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,477
Closed -$241K – 795
2025
Q3 		$241K Buy
+7,477
New +$235K 0.14% 357

Other funds holding FSBC

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's FSBC Position: Q4 2025 in Review

PharVision Advisers sold out of Five Star Bancorp (FSBC) in Q4 2025, closing a stake of 7,477 shares — an estimated $241K sold.

PharVision Advisers first reported a position in FSBC in Q3 2025 and held it in 1 quarter. The position peaked at $241K in Q3 2025. 123 funds tracked by Wall St. Rank hold FSBC as of Q4 2025.

  • PharVision Advisers reported no remaining Five Star Bancorp position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 7,477 Five Star Bancorp shares in Q4 2025, an estimated $241K.
  • PharVision Advisers first reported a position in Five Star Bancorp in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Five Star Bancorp position peaked at $241K in Q3 2025.
  • 123 funds tracked by Wall St. Rank held Five Star Bancorp as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.